Gerard Lozanski, MD
Physician, Professor
Pathology
Conditions and expertise
- Lymphomas
- Leukemia
- Blood Diseases
Locations
- The Ohio State University Wexner Medical Center
Academics and research
Department: Pathology
About
- Gender
- Male
Biography
I am a board-certified pathologist at The Ohio State University Wexner Medical Center. I specialize in hematopathology and clinical pathology, with a focus on blood diseases such as leukemia and lymphoma. My patients and colleagues can rely on me for high quality, accurate diagnostics and honest communication in every encounter.
I collaborate with a multidisciplinary team of skilled experts to ensure each patient receives personalized care tailored to their unique needs and values. In addition to my clinical responsibilities, I am passionate about educating and mentoring the next generation of providers.
I am a clinical professor and Vice-Chair of Clinical Pathology at The Ohio State University College of Medicine.
Conditions and expertise
- Blood Diseases
- Leukemia
- Lymphomas
Locations
Please note: Not all physicians schedule patients at each listed location.
Credentials
Education
- Fellowship - Hematopathology
- Cleveland Clinic Foundation, Cleveland, OH, United States
7/1/2001 - 6/30/2002 - Residency - Pathology, Anatomic Pathology & Clinical Pathology
- Summa Akron City Hospital/St. Thomas Hospital, Akron, OH, United States
7/1/1996 - 6/30/2001 - Residency - Obstetrics & Gynecology
- Poznan University of Medical Sciences, Poznan, Poland
7/1/1987 - 6/30/1990 - Doctor of Medicine (MD)
- Poznan University of Medical Sciences-Faculty 1, 61-701 Poznan, Poland
9/1/1980 - 6/30/1987
Certifications
-
American Board of Pathology
1/1/2014 -
American Board of Pathology/Hematology
9/30/2003 -
American Board of Pathology/Anatomic & Clinical
9/21/2001
Academics and research
I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC - James and also serve as the director of Hematopathology as well as the Clinical Flow Cytometry Laboratory at The Ohio State University Wexner Medical Center.
One of my recent research projects offers a rationale for combination therapy of Fc-engineered antibodies, such as BI 836858, with azanucleosides in senior citizens with acute myeloid leukemia.
I have co-authored many articles in such well-known publications as Blood, Biology of Blood and Marrow Transplantation, American Journal of Hematology and Leukemia.
Research interests
- Burkitt Lymphoma
- Gastritis
- Leukemia
- Leukemia Hairy Cell
- Leukemia Lymphocytic Chronic B Cell
- Lymphoma
- Lymphoma Follicular
- Lymphoma Mantle Cell
- Neoplasm Residual
- Neoplasms
Academic information
- Department:
- Pathology
- Division:
- Pathology
More about my research
News and media
My news coverage
- Immuno-oncology treatment pre-surgery safe, effective option for localized non-small cell lung cancer
- Ohio State To Study COVID-19 In First Responders With $10 Million Grant
- Mechanisms of Ibrutinib Resistance Identified in Chronic Leukemia
- Researchers Identify a "Life-And-Death" Molecule on Chronic Leukemia Cells
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/3/2025, Dr. Lozanski has reported no relationships with companies or entities.